Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

11.1K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.1K
Amyloid Fibrils03:03

Amyloid Fibrils

6.1K
6.1K
Cross-bridge Cycle01:26

Cross-bridge Cycle

120.6K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
120.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

Medical hypotheses·2026
Same journal

Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

Medical hypotheses·2025
Same journal

The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

Medical hypotheses·2025
Same journal

Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

Medical hypotheses·2025
Same journal

How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

Medical hypotheses·2024
Same journal

Unstable Plaque is a Treatable Cause of Cognitive Decline.

Medical hypotheses·2024
See all related articles

Related Experiment Video

Updated: Nov 16, 2025

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.9K

Mycotoxins causing amyotrophic lateral sclerosis.

William K Reid1

  • 1Hematology & Oncology, 613 Greenwood Rd., Chapel Hill, N.C. 27514, United States.

Medical Hypotheses
|February 25, 2021
PubMed
Summary
This summary is machine-generated.

This study suggests mycotoxins, a type of poison, may cause Amyotrophic Lateral Sclerosis (ALS). Antifungal treatment improved lab results in ALS patients, indicating a potential new treatment approach for this neurodegenerative disease.

Keywords:
Amyotrophic Lateral SclerosisImmune SuppressionMitochondrial dysfunctionMycotoxinsReactive oxygen species

More Related Videos

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

7.2K
Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
11:12

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells

Published on: October 4, 2017

7.4K

Related Experiment Videos

Last Updated: Nov 16, 2025

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.9K
Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

7.2K
Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
11:12

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells

Published on: October 4, 2017

7.4K

Area of Science:

  • Neuroscience
  • Toxicology
  • Immunology

Background:

  • Amyotrophic Lateral Sclerosis (ALS) is a terminal neurodegenerative disease with an unknown cause for most patients.
  • Historically, poisoning was a leading theory for ALS etiology, but previous treatments like plasma exchange failed.
  • The failure of plasma exchange suggests continued exposure to a potential toxin in ALS patients.

Purpose of the Study:

  • To investigate the potential role of poisoning, specifically mycotoxins, in the etiology of Amyotrophic Lateral Sclerosis (ALS).
  • To explore the link between mycotoxin exposure, neurotoxicity, and immune suppression in ALS patients.
  • To evaluate the efficacy of antifungal agents in treating laboratory findings associated with ALS.

Main Methods:

  • Laboratory examination of ALS patients for evidence of poisoning.
  • Specific identification of mycotoxins as potential causative agents.
  • Administration of antifungal agents to ALS patients and monitoring of laboratory markers.
  • Assessment of immune suppression in ALS patients.

Main Results:

  • Laboratory evidence of poisoning was found in all examined ALS patients.
  • Mycotoxins were identified as a likely source of poisoning.
  • Treatment with antifungal agents normalized laboratory findings in ALS patients.
  • All ALS patients exhibited evidence of immune suppression, consistent with mycotoxin effects.

Conclusions:

  • Mycotoxin exposure may be a significant factor in the development of Amyotrophic Lateral Sclerosis (ALS).
  • Mycotoxins can induce both neurotoxicity and immune suppression, potentially explaining the pathology of ALS.
  • Antifungal treatment shows promise in addressing the underlying toxicological and immunological aspects of ALS.